Nuvation Bio Inc. (NUVB) stock analysis

In our weekly check, Nuvation Bio Inc. is graded F (A to F). Of 21 checks on debt, profit, cash flow and trend: 5 pass, warnings: 3, red flags: 13.

About Nuvation Bio Inc.

Nuvation Bio Inc. is a Healthcare company (Biotechnology) based in the United States, listed on NYSE as NUVB.

What our checks show for NUVB

Red flags

Warning signs

Strengths

Similar companies

LBRX · ANAB · TYRA · OCUL · NTLA

Questions

What grade does Nuvation Bio Inc. (NUVB) have?

In our weekly check, Nuvation Bio Inc. is graded F (A to F). Of 21 checks on debt, profit, cash flow and trend: 5 pass, warnings: 3, red flags: 13. The grade is a risk check, not a buy or sell recommendation.

What are the main risks of NUVB stock?

This week's biggest flags for Nuvation Bio Inc.: High debt, Weak interest cover, Margins falling. In total 16 of 21 checks show a warning or a red flag.

What does Nuvation Bio Inc. do?

Nuvation Bio Inc. is a Healthcare company (Biotechnology) based in the United States, listed on NYSE as NUVB.

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-11-14

Open the full analysis